Cited by 23Extracellular vesicles in diseaseMicroRNA in disease regulationAbdominal vascular conditions and treatments

Intestinal epithelial cell-derived exosomes package microRNA-23a-3p alleviate gut damage after ischemia/reperfusion via targeting MAP4K4

Open access
Yang, Jin, Zheng, Xin Guo, Wu, Yan Ling, Wang, Ai Ping, Wang, Chen Hui, Chen, Wen Xin, Zhong, Shan, Yang, Hui·2022·Biomedicine & Pharmacotherapy

Published version of a preprint

Abstract

Abstract Backgroud: Intestinal epithelial cells (IEC) contribute to regulate gut injury after intestinal isochemia/reperfusion (II/R). Exosomes are well documented to deliver bioactive molecules to recipient cells to modulate cell function. However, the role of IEC-derived exosomes in gut damage after II/R and the underlying mechanisms remains unclear. Methods IEC-derived exosomes were intravenously injected into the rats after the superior mesenteric artery occlusion for 45 min following reperfusion for 6h. The scores of gut injury, ZO-1 and IL-17A expression, TNF-α and endotoxin concentration were determined at 3 days after II/R assault. Exosomal microRNA-23a-3p and its downstream target molecule-MAP4K4 were also detected. Results Our results showed that the IEC-derived exosomes attenuated the damage of IECs after oxygen-glucose deprivation in vitro (p<0.05) and the degree of gut injury at 3 days after II/R assault in vivo (p<0.05). Injection of miR-23a-3p knockdown exosomes derived from IECs aggravated the II/R injury whereas PF-6260933, a small-molecule inhibitor of MAP4K4, was partly reversed the injuried degree by intraperitoneal injection. Underlying mechanism studies revealed that exosomal miR-23a-3p attenuated gut damage by regulating its downstream target MAP4K4. Conclusions We demonstrated that IEC-derived exosomes alleviated the II/R injury and promoted gut damage recovery via exosomal miR-23a-3p and its downstream target molecule-MAP4K4.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2022.112810

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Exosomal miR-23a-3p from intestinal epithelial cells knockdown intensified gut injury after intestinal ischemia/reperfusion by targeting MAP4K4.

    “Research has also revealed that exosomal miR-23a-3p from intestinal epithelial cells (IECs) knockdown intensified gut injury after intestinal ischemia/reperfusion (II/R) by targeting MAP4K4 [40].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 23

Research works printed but not linked: 3

  1. Z.Y. Wang, R.M. Sun, G.Z. Wang, Z.C. Chen, Y. Li, Y. Zhao, D.S. Liu, H.Y. Zhao, F. Zhang, J.H. Yao, X.F. Tian, SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/ reperfusion injury, Redox Biol. 28 (2020), 101343.
  2. G. Akbari, Emerging roles of microRNAs in intestinal ischemia/reperfusion- induced injury: a review, J. Physiol. Biochem. 76 (4) (2020) 525-537.
  3. L.X. Li, L.H. Yin, M. Gao, L.N. Xu, Y. Qi, J.Y. Peng, MiR-23a-5p exacerbates intestinal ischemia-reperfusion injury by promoting oxidative stress via targeting PPAR alpha, Biochem. Pharm. 180 (2020), 114194.

Authors
Yang, J., Zheng, X. G., Wu, Y. L., Wang, A. P., Wang, C. H., Chen, W. X., Zhong, S., & Yang, H.
Affiliations
  • Army Medical University (CN)
  • Nanjing Children's Hospital (CN)
Corresponding author
  • Zhong, Shan
  • Yang, Hui
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2022-05
Volume
149
Pages
112810
ISSN
0753-3322 (ISSN-L)
OpenAlex
W4220737326
Cited by
23
References
30
Citations by year
2026: 5 · 2025: 10 · 2024: 4 · 2023: 3 · 2022: 1
FWCI
1.47
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • Research Square (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Third Military Medical University (SKLKF202006)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
Keywords
exosomes, intestinal epithelial cells, MAP4K4, intestinal ischemia-reperfusion injury, gut damage, oxygen-glucose deprivation, exosomal microRNA delivery
MeSH terms
Animals, Epithelial Cells, Glucose, Ischemia, Oxygen, Reperfusion, Reperfusion Injury, MicroRNAs, Rats, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review